Ketamine Completed Phase 2 Trials for Depression Other

IndicationsStatusPurposePhase
CompletedOther2
clinicaltrials.gov IdentifierTitleDrugs
NCT02487485Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects